Okairos(意大利)

Okairos

意大利Okairoswww.okairos.comOkairos公司有一個(gè)好的開(kāi)端--自從從默沙東公司剝離出來(lái)后，它已得到來(lái)自BioMedlnvest、勃林格殷格翰（BoehringerIngelheim）公司風(fēng)險(xiǎn)基金、LSP、諾華（Novartis）公司風(fēng)險(xiǎn)基金和VersantVentures公司的支持。其疫苗技術(shù)在預(yù)防呼吸道合胞病毒和流感病毒方面也具有很大的潛力。目前已有許多生物技術(shù)公司在專(zhuān)注 于丙型肝炎疫苗的開(kāi)發(fā)2013年GSK2.5億歐元收購(gòu)瑞士疫苗平臺(tái)OkairosAG Weareaclinical-stagebiopharmaceuticalcompanyspunoutfromMerckin2007.OurheadquartersareinBaselandwehavelaboratoriesinRomeandNaples.Ourfounders,RiccardoCorteseandhisteam,werealsothefoundersofIstitutodiRicerchediBiologiaMolecolare(IRBM),whichlaterbecameasubsidiaryofMerckInc.WhileatIRBM,theymadesignificantcontributionstothefieldofinfectiousdiseases,includingelucidationofthemechanismofactionofthehepatitisCproteaseandpolymeraseenzymes,anddiscoveryoftheHIVfusioninhibitorISENTRESS®.Todaywearedevelopinggeneticvaccinesformajorinfectiousdiseases,includinghep